Aptargroup

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptargroup and other ETFs, options, and stocks.

About ATR

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty, Closures, and Corporate and Other. 

CEO
Gael Touya
CEOGael Touya
Employees
14,000
Employees14,000
Headquarters
Crystal Lake, Illinois
HeadquartersCrystal Lake, Illinois
Founded
1940
Founded1940
Employees
14,000
Employees14,000

ATR Key Statistics

Market cap
7.91B
Market cap7.91B
Price-Earnings ratio
22.50
Price-Earnings ratio22.50
Dividend yield
1.54%
Dividend yield1.54%
Average volume
551.95K
Average volume551.95K
High today
$125.98
High today$125.98
Low today
$124.18
Low today$124.18
Open price
$125.09
Open price$125.09
Volume
484.39K
Volume484.39K
52 Week high
$146.91
52 Week high$146.91
52 Week low
$103.23
52 Week low$103.23

Stock Snapshot

The current Aptargroup(ATR) stock price is $124.51, with a market capitalization of 7.91B. The stock trades at a price-to-earnings (P/E) ratio of 22.50 and offers a dividend yield of 1.54%.

On 2026-10-18, Aptargroup(ATR) stock traded between a low of $124.18 and a high of $125.98. Shares are currently priced at $124.51, which is +0.3% above the low and -1.2% below the high.

Aptargroup(ATR) shares are trading with a volume of 484.39K, against a daily average of 551.95K.

During the past year, Aptargroup(ATR) stock moved between $103.23 at its lowest and $146.91 at its peak.

During the past year, Aptargroup(ATR) stock moved between $103.23 at its lowest and $146.91 at its peak.

ATR News

Simply Wall St 3d
Is EU Vaccine Device Approval Altering The Investment Case For AptarGroup?

AptarGroup’s Aptar Pharma segment has received CE marking under the EU Medical Device Regulation for its LuerVax intranasal delivery device and Spray Divider, c...

Is EU Vaccine Device Approval Altering The Investment Case For AptarGroup?

Analyst ratings

85%

of 13 ratings
Buy
84.6%
Hold
15.4%
Sell
0%

People also own

Based on the portfolios of people who own ATR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.